Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Peter Stopfer
Introduction
Peter Stopfer is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms. His work focuses on delivering effective medication through innovative formulations.
Latest Patents
Peter Stopfer holds a patent for a pharmaceutical dosage form designed for the immediate release of an indolinone derivative. This invention relates to a pharmaceutical dosage form that delivers an immediate release profile containing the active substance 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate. This patent showcases his expertise in creating effective pharmaceutical solutions.
Career Highlights
Peter Stopfer is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to contribute to the development of innovative healthcare solutions. His work has been instrumental in advancing pharmaceutical formulations that improve patient outcomes.
Collaborations
Throughout his career, Peter has collaborated with several talented individuals, including Roman Messerschmid and Peter Lach. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Peter Stopfer's contributions to the pharmaceutical industry through his innovative patent and collaborative efforts highlight his commitment to advancing healthcare solutions. His work continues to impact the field positively, demonstrating the importance of innovation in pharmaceuticals.